Clinical Trial Update: GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS) [Phase 2]

View source ↗

Summary

Phase 2A randomized, double-blind, placebo-controlled pilot trial of GM604 in amyotrophic lateral sclerosis completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• GM604

Snippet

Sponsor: Genervon Biopharmaceuticals, LLC | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED